Aug 18, 2015

Study compares heparin to warfarin for treatment of blood clots in patients with cancer -- ScienceDaily

Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for 6 months compared with warfarin did not significantly reduce recurrent VTE and was not associated with reductions in overall death or major bleeding, but was associated with a lower rate of clinically relevant...

Proceed to the page: http://linkis.com/CbVFw

Similar Articles Added Earlier

Similar Articles Added Today

Most Recent sciencedaily.com Articles

Latest Links Processed

0/120